HomeCompareGNGBY vs KMB

GNGBY vs KMB: Dividend Comparison 2026

GNGBY yields 2.32% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GNGBY wins by $124.05M in total portfolio value· pulled ahead in Year 2
10 years
GNGBY
GNGBY
● Live price
2.32%
Share price
$20.57
Annual div
$0.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$124.10M
Annual income
$114,616,754.52
Full GNGBY calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — GNGBY vs KMB

📍 GNGBY pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNGBYKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNGBY + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GNGBY pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNGBY
Annual income on $10K today (after 15% tax)
$197.38/yr
After 10yr DRIP, annual income (after tax)
$97,424,241.34/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, GNGBY beats the other by $97,419,811.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNGBY + KMB for your $10,000?

GNGBY: 50%KMB: 50%
100% KMB50/50100% GNGBY
Portfolio after 10yr
$62.07M
Annual income
$57,310,982.92/yr
Blended yield
92.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

GNGBY
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
2.6
Piotroski
6/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNGBY buys
0
KMB buys
0
No recent congressional trades found for GNGBY or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNGBYKMB
Forward yield2.32%5.25%
Annual dividend / share$0.48$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%17%
Portfolio after 10y$124.10M$45.9K
Annual income after 10y$114,616,754.52$5,211.33
Total dividends collected$123.36M$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold

Year-by-year: GNGBY vs KMB ($10,000, DRIP)

YearGNGBY PortfolioGNGBY Income/yrKMB PortfolioKMB Income/yrGap
1$11,164$464.43$11,314$613.68$150.00KMB
2← crossover$12,915$969.18$12,865$759.19+$50.00GNGBY
3$15,915$2,095.61$14,709$943.96+$1.2KGNGBY
4$21,856$4,826.80$16,919$1,180.17+$4.9KGNGBY
5$35,775$12,389.91$19,588$1,484.33+$16.2KGNGBY
6$76,188$37,908.46$22,838$1,879.06+$53.4KGNGBY
7$232,420$150,898.52$26,832$2,395.60+$205.6KGNGBY
8$1,109,122$860,432.66$31,788$3,077.63+$1.08MGNGBY
9$8,861,597$7,674,836.93$38,000$3,986.82+$8.82MGNGBY
10$124,098,664$114,616,754.52$45,872$5,211.33+$124.05MGNGBY

GNGBY vs KMB: Complete Analysis 2026

GNGBYStock

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Full GNGBY Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this GNGBY vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNGBY vs SCHDGNGBY vs JEPIGNGBY vs OGNGBY vs KOGNGBY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.